GT
PFE icon

Glenmede Trust’s Pfizer PFE Stock Holding History

Glenmede Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-59
Closed -$9K – 1243
2020
Q4 		$9K Buy
+59
New +$2.16K ﹤0.01% 1170

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Glenmede Trust's PFE Position: Q1 2026 in Review

Glenmede Trust reduced its Pfizer (PFE) stake by 5.6% in Q1 2026, selling an estimated $1.41M and leaving 902,032 shares worth $25.3M. The position accounts for 0.12% of the portfolio, ranked #140.

Glenmede Trust first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $227M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Glenmede Trust held 902,032 shares of Pfizer worth $25.3M as of Q1 2026.
  • Glenmede Trust sold 53,129 Pfizer shares in Q1 2026, an estimated $1.41M.
  • Pfizer made up 0.12% of Glenmede Trust's portfolio in Q1 2026, its #140 holding.
  • Glenmede Trust first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Pfizer position peaked at $227M in Q3 2018.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.